In addition to its reported antiviral activities, TRIM56 has also been implicated in regulating innate immune-signaling pathways that culminate in the induction of type I interferon (IFN-I) response, a hallmark of the intrinsic, immediate defense mechanisms of mammalian hosts against viral infections. The gene discussed is TRIM56; the disease is viral infectious disease.